Not logged in Share Save
Pembrolizumab plus lenvatinib for previously untreated advanced non-clear cell renal cell carcinoma: 3-year follow-up of the phase 2 KEYNOTE-B61 study Albiges, Laurence; Gurney, Howard; Lee, Jae Lyun; Atduev, Vagif; Suarez, Cristina; Climent, Miguel A.; Pook, David; Tomczak, Piotr; Barthelemy, Philippe; Gedye, Craig; Lacombe, Louis; Ferguson, Thomas; Stus, Viktor; Wiechno, Pawel; Erman, Mustafa; Urun, Yuksel; Cornell, Jerry; Burgents, Joe; Sharma, Manish; Voss, Martin Share Save
Share Save
Share Save
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma Choueiri, T. K.; Tomczak, P.; Park, S. H.; Venugopal, B.; Ferguson, T.; Symeonides, S. N.; Hajek, J.; Chang, Y-H; Lee, J-L; Sarwar, N.; Haas, N. B.; Gurney, H.; Sawrycki, P.; Mahave, M.; Gross-Goupil, M.; Zhang, T.; Burke, J. M.; Doshi, G.; Melichar, B.; Kopyltsov, E.; Alva, A.; Oudard, S.; Topart, D.; Hammers, H.; Kitamura, H.; McDermott, D. F.; Silva, A.; Winquist, E.; Cornell, J.; Elfiky, A.; Burgents, J. E.; Perini, R. F.; Powles, T. Share Save
Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial Pal, Sumanta Kumar; Albiges, Laurence; Tomczak, Piotr; Suarez, Cristina; Voss, Martin H.; de Velasco, Guillermo; Chahoud, Jad; Mochalova, Anastasia; Procopio, Giuseppe; Mahammedi, Hakim; Zengerling, Friedemann; Kim, Chan; Osawa, Takahiro; Angel, Martin; Gupta, Suyasha; Khan, Omara; Bergthold, Guillaume; Liu, Bo; Kalaitzidou, Melania; Huseni, Mahrukh; Scheffold, Christian; Powles, Thomas; Choueiri, Toni K. Share Save
Removal of soluble TNF receptors as a novel form of immunotherapy for patients with advanced solid tumors Wysocki, Piotr J.; Tomczak, Piotr; Jankowski, Tomasz; Nowikiewicz, Tomasz; Markel, Gal; Shapira, Ronnie; Demir, Gokhan; Bozkurt, Mustafa; Bilgrami, Sameera; Marleau, Annette; Ostrowski, Adam; Florin, Lawrence; Manax, Victoria; Segal, Robert Share Save
Quantum versus classical nature of the low-temperature magnetic phase transition in TbAl3(BO3)4 Zajarniuk, T.; Szewczyk, A.; Wisniewski, P.; Gutowska, M. U.; Puzniak, R.; Szymczak, H.; Gudim, I; Bedarev, V. A.; Pashchenko, M., I; Tomczak, P.; Szuszkiewicz, W. Share Save
Pembrolizumab (pembro) vs placebo as adjuvant therapy for patients (pts) with renal cell carcinoma (RCC): Patient-reported outcomes (PRO) in KEYNOTE-564 Choueiri, T. K.; Tomczak, P.; Park, S. H.; Venugopal, B.; Symeonides, S.; Hajek, J.; Ferguson, T.; Chang, Y-H.; Lee, J. L.; Haas, N.; Sawrycki, P.; Sarwar, N.; Gross-Goupil, M.; Thiery-Vuillemin, A.; Mahave, M.; Saretsky, T. L.; Zhang, P.; Willemann-Rogerio, J.; Quinn, D. I.; Powles, T. B. Share Save
Pembrolizumab (pembro) monotherapy as first-line therapy in advanced non-clear cell renal cell carcinoma (nccRCC): Results after a minimum of 34 months of follow-up from KEYNOTE-427 cohort B Lee, J-L.; McDermott, D. F.; Ziobro, M.; Suarez, C.; Langiewicz, P.; Matveev, V. B.; Wiechno, P.; Gafanov, R.; Tomczak, P.; Pouliot, F.; Donskov, F.; Alekseev, B. Y.; Shin, S. J.; Bjarnason, G. A.; Castellano, D.; Liu, H.; Burgents, J.; Rodriguez-Lopez, K.; Atkins, M. B. Share Save
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma Choueiri, T. K.; Tomczak, P.; Park, S. H.; Venugopal, B.; Ferguson, T.; Chang, Y. -H.; Hajek, J.; Symeonides, S. N.; Lee, J. L.; Sarwar, N.; Thiery-Vuillemin, A.; Gross-Goupil, M.; Mahave, M.; Haas, N. B.; Sawrycki, P.; Gurney, H.; Chevreau, C.; Melichar, B.; Kopyltsov, E.; Alva, A.; Burke, J. M.; Doshi, G.; Topart, D.; Oudard, S.; Hammers, H.; Kitamura, H.; Bedke, J.; Perini, R. F.; Zhang, P.; Imai, K.; Willemann-Rogerio, J.; Quinn, D. I.; Powles, T. Share Save
Share Save
Share Save
Pembrolizumab monotherapy for the adjuvant treatment of renal cell carcinoma post-nephrectomy: Randomized, double-blind, Phase III KEYNOTE-564 study Choueiri, Toni K.; Quinn, David I.; Zhang, Tian; Gurney, Howard; Doshi, Gurjyot K.; Cobb, Patrick Wayne; Parnis, Francis; Lee, Jae-Lyun; Park, Se Hoon; Semenov, Andrey; Thiery-Vuillemin, Antoine; Sawrycki, Piotr; Tomczak, Piotr; Alekseev, Boris; Izmailov, Adel; Chang, Wayne Yen-Hwa; Wan, Shuyan M.; Poehlein, Christian Heinrich; Willemann-Rogerio, Jaqueline; Powles, Thomas Share Save
Share Save
Share Save
Share Save
Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results Motzer, Robert J.; Ravaud, Alain; Patard, Jean-Jacques; Pandha, Hardev S.; George, Daniel J.; Patel, Anup; Chang, Yen-Hwa; Escudier, Bernard; Donskov, Frede; Magheli, Ahmed; Carteni, Giacomo; Laguerre, Brigitte; Tomczak, Piotr; Breza, Jan; Gerletti, Paola; Lechuga, Mariajose; Lin, Xun; Casey, Michelle; Serfass, Lucile; Pantuck, Allan J.; Staehler, Michael Share Save
Share Save
ADJUVANT SUNITINIB IN PATIENTS WITH HIGH RISK RENAL CELL CARCINOMA: SUBGROUP ANALYSES FROM S-TRAC TRIAL Pantuck, Allan; Patard, Jean-Jacques; Patel, Anup; Ravaud, Alain; Motzer, Robert J.; Pandha, Hardev S.; George, Daniel J.; Chang, Yen-Hwa; Escudier, Bernard; Donskov, Frede; Magheli, Ahmed; Carteni, Giacomo; Laguerre, Brigitte; Tomczak, Piotr; Breza, Jan; Gerletti, Paola; Lechuga, Mariajose; Lin, Xun; Casey, Michelle; Staehler, Michael Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
